Get the Stockscreener App
1.55
4.73%
0.07
After Hours:
1.49
-0.06
-3.87%
Codexis Inc stock is traded at $1.55, with a volume of 4.02M.
It is up +4.73% in the last 24 hours and down -35.15% over the past month.
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
See More
Previous Close:
$1.48
Open:
$1.49
24h Volume:
4.02M
Relative Volume:
3.51
Market Cap:
$140.89M
Revenue:
$78.09M
Net Income/Loss:
$-31.99M
P/E Ratio:
-4.27
EPS:
-0.363
Net Cash Flow:
$-22.12M
1W Performance:
-29.86%
1M Performance:
-35.15%
6M Performance:
+8.39%
1Y Performance:
-50.16%
1-Day Range:
$1.48
$1.635
1-Week Range:
$1.44
$2.299
52-Week Range:
$0.9583
$3.87
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis Inc
Sector
Industry
Phone
650-421-8100
Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA
Compare CDXS vs VRTX, REGN, ARGX, RVMD, ALNY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CDXS
Codexis Inc
|
1.55 | 134.53M | 78.09M | -31.99M | -22.12M | -0.363 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Codexis Inc Stock (CDXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-24 | Downgrade | The Benchmark Company | Buy → Hold |
| Jun-03-24 | Resumed | Jefferies | Buy |
| May-30-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-29-24 | Upgrade | The Benchmark Company | Hold → Buy |
| Nov-07-23 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-07-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| May-09-23 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Mar-31-22 | Resumed | Piper Sandler | Overweight |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Apr-12-21 | Initiated | Piper Sandler | Overweight |
| Mar-01-21 | Initiated | Stifel | Buy |
| Feb-26-21 | Reiterated | H.C. Wainwright | Buy |
| Mar-10-20 | Initiated | The Benchmark Company | Buy |
| Jan-17-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| May-16-18 | Initiated | Stephens | Overweight |
| Oct-13-17 | Reiterated | H.C. Wainwright | Buy |
| May-31-17 | Initiated | Jefferies | Buy |
| Jan-26-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Jan-04-17 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Jan-06-16 | Initiated | H.C. Wainwright | Buy |
View All
Codexis Inc Stock (CDXS) Latest News
Codexis Inc (CDXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Codexis prices $25.0M equity offering, nets ~$23.1M after fees - TradingView
Codexis Inc (CDXS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Codexis Inc (CDXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CDXS|Codexis Inc|Price:1.520|Chg%:+0.040 - TradingKey
CDXS Stock Falls As Codexis Prices Dilutive Share Offering - timothysykes.com
Codexis: ECO Synthesis And Runway Reset Warrant An Upgrade (Rating Upgrade) - Seeking Alpha
TradingKey - TradingKey
Codexis Market Sentiment - Benzinga España
Codexis, Inc. Revenue Breakdown – TRADEGATE:4QK - TradingView
Codexis Inc (CDXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CDXS|Codexis Inc|Price:1.545|Chg%:+0.065 - TradingKey
Codexis Inc (CDXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
CDXS Secures Funding with Piper Sandler and Cantor Fitzgerald - GuruFocus
Crude Oil Down Over 4%; Verizon Raises Earnings Forecast - Benzinga
CDXS Stock Slides As Dilutive Offering Reshapes Trading Setup - StocksToTrade
Codexis Expects Net Proceeds of About $23.1M From the Offering >CDXS - Moomoo
Codexis (CDXS) Faces 25.4% Drop Ahead of Market Open - GuruFocus
Codexis Intends to Use Net Proceeds to Fund Working Capital, Other General Corporate Purposes >CDXS - Moomoo
Form 424B5 Codexis Inc For: 24 July By Investing.com - Investing.com Nigeria
Codexis Shares Slide on Public Offering Price - Moomoo
Codexis Expects Offering to Close on or About July 27 >CDXS - Moomoo
Codexis Prices 16.7 Million Shares at $1.50 in Public Stock Offering - Moomoo
BRIEF-Codexis Announces Pricing Of Public Offering Of Common Stock - Bitget
Codexis prices 16,666,667-share common stock offering at $1.5 per share - Bitget
Codexis (CDXS) Launches Public Offering at $1.50 per Share - GuruFocus
Codexis Inc (CDXS) Institutional Confidence - TradingKey
Why Codexis Stock Is Falling After Hours TodayCodexis (NASDAQ:CDXS) - Benzinga
Aberdeen Group plc Reduces Stake in Codexis Inc: A Strategic Por - GuruFocus
Codexis Announces Pricing of Public Offering of Common Stock - The Manila Times
Codexis Prices $25 Million Underwritten Public Offering of Common Stock - Quiver Quantitative
Codexis Announces Pricing of Public Offering of Common Stock - GlobeNewswire Inc.
Aberdeen Group plc Reduces Stake in Codexis Inc: A Strategic Portfolio Adjustment - GuruFocus
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Codexis Announces Proposed Public Offering of Common Stock - The Manila Times
CDXS Q2'26 Earnings: revenue estimate is 13.82M USD - TradingView
Top Penny Stocks To Watch In July 2026 - simplywall.st
Aberdeen Group plc (CDXS) discloses 6.77M-share Codexis stake held via abrdn Inc. - Stock Titan
CDXS Q1 2026 Earnings: EPS Surpasses Estimates by 28.26%, Shares RiseUpward Estimate Revision - dars.gov.et
Price to earnings forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
CDXS News | CODEXIS INC (NASDAQ:CDXS) - ChartMill
CDXS Stock Price, Quote & Chart - ChartMill
CDXS Q1 2026 Earnings: EPS Surprise Highlights Cost Discipline Amid Revenue DisclosuresEarnings Expansion Phase - dars.gov.et
Codexis Inc. (CDXS) Slips 2.5% as Shares Test Key Support LevelsVirgin POC - dars.gov.et
Codexis Inc. (CDXS) Slips 2.5% Amid Selling Pressure; Support Level in FocusAdvance Decline Volume - dars.gov.et
Enterprise value to revenue forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
CDXS Q1 2026 Earnings: EPS Beat Drives 6.22% Stock GainEarnings Surprise Score - DonanımHaber
Enterprise value to EBITDA forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
US$6.58: That's What Analysts Think Codexis, Inc. (NASDAQ:CDXS) Is Worth After Its Latest Results - 富途牛牛
Price to book forward of Codexis, Inc. – NASDAQ:CDXS - TradingView
Price to book forward of Codexis, Inc. – LSX:A0Q2S4 - TradingView
Codexis Inc Stock (CDXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.97%
0.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):